Related by context. All words. (Click for frequent words.) 76 Ambrisentan 76 Golimumab 75 Romiplostim 73 Certican 73 rasagiline tablets 73 INSPIRE Trial Phase III 73 Pivotal Phase III 72 Dasatinib 72 Daclizumab 72 methylnaltrexone bromide 72 Amrubicin 72 TEMODAL 72 Ixempra 72 Meets Primary Endpoint 72 Cetrorelix 72 Clolar ® 72 Safinamide 72 Pulmonary Arterial Hypertension 71 acyclovir Lauriad R 71 Raptiva ® 71 Lubiprostone 71 SinuNase TM 71 Evoltra 71 FOLOTYN ® 71 interferon gamma 1b 71 sorafenib tablets 71 Rivaroxaban 71 IRESSA 71 Personalized Immunotherapy 71 Boceprevir 71 Firazyr 71 Ceflatonin R 71 Glufosfamide 71 Eculizumab 71 Actimmune ® 71 Everolimus 71 Archexin 71 Tezampanel 71 YONDELIS 71 Dabigatran etexilate 71 Alemtuzumab 71 Combination REOLYSIN R 71 Paliperidone Palmitate 71 Phase III Clinical Trials 71 Dapagliflozin 71 LymphoStat B belimumab 71 Muraglitazar 71 Ocrelizumab 71 GTC recombinant human 70 SNT MC# 70 Bayer Nexavar 70 Dalbavancin 70 RoACTEMRA 70 Epratuzumab 70 Denufosol 70 Vandetanib 70 JAK Inhibitor 70 Febuxostat 70 Phase III Clinical Trial 70 Catena ® 70 oral dual endothelin 70 Icatibant 70 Elagolix 70 Actemra tocilizumab 70 Phase III Trial 70 Vitrasert R 70 Marketing Authorisation Application 70 RANK Ligand inhibitor 70 Investigational Treatment 70 UPLYSO 70 Mipomersen 70 NDA Submission 70 Hsp# Inhibitor 70 GW# [003] 70 Pazopanib 70 Zarnestra 70 Rilonacept 70 Temsirolimus 70 Naproxcinod 70 Pemetrexed 70 AVASTIN 70 Torisel 70 Adjuvant Treatment 70 Alvesco R 70 Nexavar sorafenib 70 RhuDex ® 70 SAFLUTAN 70 Desvenlafaxine 70 Satraplatin 70 Patient Enrollment 70 Degarelix 70 Phase 2b Clinical Trial 70 Tesamorelin 70 Investigational Compound 70 Tasigna nilotinib 70 Onbrez Breezhaler 69 Brilique 69 Completes Patient Enrollment 69 Pafuramidine 69 Ofatumumab 69 tocilizumab 69 Civacir 69 Etanercept 69 pseudobulbar affect PBA 69 BRILINTA 69 Ridaforolimus 69 Aflibercept 69 Jevtana 69 Fondaparinux 69 Pixuvri 69 Ustekinumab 69 rilonacept 69 ONGLYZA ™ 69 thetreatment 69 Liprotamase 69 Silodosin 69 ZOLINZA 69 Clinical Trial Results 69 Genentech Rituxan 69 Trobalt 69 Sapacitabine 69 Mycamine 69 Hepatocellular Carcinoma 69 Raptiva R 69 lucinactant 69 OMAPRO ™ 69 Serdolect ® 69 Ceflatonin 69 Clofarabine 69 Junovan 69 reslizumab 69 Lenalidomide 69 MKC# MKC# PP 69 PF # [002] 69 Betaferon R 69 Noxafil 69 Peginterferon alfa 2b 69 Hormone Refractory Prostate Cancer 69 Irinotecan 69 Pivotal Trial 69 Arzerra ofatumumab 69 Application MAA 69 Severe Sepsis 69 Nexavar ® 69 Retacrit 69 solifenacin succinate 69 Moxifloxacin 69 Pfizer Sutent 69 Aviptadil 69 Long Term Efficacy 69 Celgene Revlimid 69 Glatiramer Acetate 69 Humira adalimumab 69 Tarceva TM 69 Panzem R 69 Granted Orphan Drug 69 Mirapexin 69 Bevacizumab 69 Bucindolol 69 RhuDex 69 BLP# Liposome Vaccine 69 STELARA TM 69 Traficet EN 69 Anidulafungin 69 ORENCIA ® 69 Onrigin 69 Initiates Phase III 69 Eloxatin ® 69 Bosutinib 69 Oral Fingolimod 69 Vernakalant 69 Phase 2a Trial 68 Proxinium TM 68 Lung Cancer Drug 68 Drug Candidate 68 Velcade bortezomib 68 Vicriviroc 68 PEGylated Fab fragment 68 Toremifene 68 Mycophenolate Mofetil 68 Prolongs Survival 68 Pertuzumab 68 Bezielle 68 VIVITROL ® 68 Ozarelix 68 Receives Orphan Drug Designation 68 SUTENT ® 68 Cimzia TM 68 Hycamtin 68 FDA APPROVES 68 Ventavis 68 TNF Tumor Necrosis Factor 68 Achieves Primary Endpoint 68 Cladribine 68 Avastin bevacizumab 68 Fabry Disease 68 Orazol 68 Aryplase 68 First Patient Enrolled 68 Tanespimycin 68 Clevudine 68 Friedreich Ataxia FRDA 68 Cimzia ® certolizumab pegol 68 Evoltra TM 68 Ceflatonin ® 68 Gleevec Glivec 68 LibiGel ® 68 ixabepilone 68 RSR# 68 GATTEX TM 68 CDP# 68 Oracea TM 68 Phase Ib IIa 68 Evoltra ® 68 riociguat 68 Shows Efficacy 68 Levoleucovorin 68 Deferiprone 68 Actemra 68 Pivotal Phase 68 Advanced Renal Cell 68 Diabetic Macular Edema 68 BAY #-# 68 Ramelteon 68 ACTEMRA TM 68 Fibrin Pad 68 Ticagrelor 68 BRIM2 68 Carfilzomib 68 Genasense ® 68 Pegloticase 68 Initiates Enrollment 68 diabetic neuropathic pain 68 Esbriet ® 68 Ranolazine 68 Sebivo 68 icatibant 68 Phase IIb Trial 68 ThermoDox R 68 Teriparatide 68 novel oral anticoagulant 68 BARACLUDE R 68 Xyrem ® 68 Microplasmin 68 Teva Provides Update 68 IL# PE#QQR 68 Angiox ® 68 Saxagliptin 68 Elesclomol 68 Xinlay 68 vapreotide acetate 68 Lambert Eaton Myasthenic 68 Tolvaptan 68 Advanced Melanoma 68 alvimopan 68 metastatic hormone refractory 68 Metastatic Colorectal Cancer 68 Dupuytren Contracture 68 Fingolimod 68 Afatinib 68 LEVADEX TM 68 Dacogen injection 68 docetaxel Taxotere ® 68 DU #b 68 XYOTAX TM 68 ALVESCO R 68 Vidaza azacitidine 68 R sorafenib tablets 68 CRMD# 68 Tavocept 68 HuMax EGFr 68 Tocilizumab 68 eltrombopag 68 NVA# 68 CTAP# Capsules 68 efalizumab 68 Telavancin 68 SPRYCEL ® 68 refractory chronic lymphocytic 68 AZILECT ® 68 Certolizumab pegol 68 Aliskiren 68 Phase 2a Clinical Trial 68 Neupro R 68 Bazedoxifene 68 Trandolapril 68 liver resection surgeries 68 BRIM3 68 virus HCV protease inhibitor 68 Candesartan 68 Roflumilast 67 Granulocyte Colony Stimulating Factor 67 mertansine 67 BioNumerik 67 Campath ® 67 Fablyn 67 HFA MDI 67 aripiprazole Abilify 67 Methylnaltrexone 67 Generic Version 67 Mg Usa 67 Pirespa 67 nilotinib Tasigna 67 KRN# 67 acetonide FA 67 Serostim ® 67 relapsing remitting MS RRMS 67 R bortezomib 67 Roche Xeloda 67 Iluvien ® 67 Receives Positive Opinion 67 Glycopyrrolate 67 Bayer Onyx 67 Asmanex 67 cetuximab Erbitux 67 thalidomide Thalomid 67 Aceon 67 Enzyme Replacement Therapy 67 Gout Drug 67 Study Evaluating 67 ospemifene 67 phase IIb clinical 67 Zenpep 67 ACOMPLIA R 67 nasal calcitonin product 67 Mylan Receives Approval 67 Lu AA# 67 Patients Treated With 67 generation purine nucleoside 67 Pralatrexate 67 YONDELIS R 67 receptor tyrosine kinase inhibitor 67 Crofelemer budesonide foam 67 Gefitinib 67 Interferon Alpha 67 Deforolimus 67 Somatuline Depot 67 Renal Cell Carcinoma 67 methylnaltrexone 67 Pivotal Study 67 Subgroup Analysis 67 Gemcitabine 67 Vimpat R 67 octreotide acetate 67 Fulvestrant 67 Vectibix panitumumab 67 Cancidas 67 Marketing Authorization Application 67 Fodosine 67 Prospective Randomized 67 MAGE A3 ASCI 67 ZACTIMA 67 AstraZeneca Iressa 67 CONBRIZA 67 Valsartan 67 Nilotinib 67 STRIDE PD 67 Tasimelteon 67 Omapro 67 RELOVAIR ™ 67 Phase III Pivotal 67 Randomized Phase 67 miconazole Lauriad R 67 Vimpat ® lacosamide 67 Chronic Lymphocytic Leukemia 67 Tocosol Paclitaxel 67 Phenoptin 67 BYETTA ® 67 Desmoteplase 67 Zorbtive TM 67 Acute Heart Failure 67 NOXAFIL 67 MOVIPREP R 67 RoActemra 67 Elvitegravir 67 Betaferon ® 67 Bronchitol 67 Erlotinib 67 Initiate Clinical Trial 67 Rheumatoid Arthritis Drug 67 regorafenib 67 CAELYX 67 oral salmon calcitonin 67 Tarceva erlotinib 67 mTOR inhibitor 67 Lupus Nephritis 67 Abatacept 67 AA Amyloidosis 67 Celebrex celecoxib 67 compound INCB# 67 Successfully Completes Phase 67 FDA Accepts 67 Hedgehog Pathway Inhibitor 67 LEVADEX ™ 67 gastrointestinal stromal tumors GIST 67 Ferumoxytol 67 Pivotal Clinical Trial 67 liposomal formulation 67 HuMax CD4 67 IMA# 67 Tracleer R 67 Prostate AdenoCarcinoma Treatment 67 etanercept Enbrel 67 aclidinium bromide 67 Zactima 67 Sycrest 67 Prestara 67 DASISION 67 Oxaliplatin 67 product Fentanyl TAIFUN 67 Belimumab 67 Fast Track Status 67 Cethromycin 67 Mepact 67 Kuvan sapropterin dihydrochloride 67 Positive Opinion 67 Schizophrenia Drug 67 sorafenib Nexavar 67 PD LID 67 Initiates Clinical 67 Argatroban 67 induced macular edema 67 Pooled Analysis 67 Psoriasis Drug 67 atypical Hemolytic Uremic Syndrome 67 adalimumab Humira 67 Advagraf 67 lapatinib Tykerb 67 investigational therapies 67 Amgen Vectibix 67 Receives Orphan Drug 67 Newly Diagnosed Multiple Myeloma 67 Initiates Phase II 67 IgG1 monoclonal antibody 67 terlipressin 66 Orphan Status 66 Yondelis ® 66 CIMZIA ™ 66 systemic fungal infections 66 Tigecycline 66 Cholesterol Lowering Drug 66 Arimoclomol 66 QNEXA 66 SNT-MC#/idebenone 66 TBC# 66 SYCREST 66 Camptosar ® 66 TAXUS Element Paclitaxel Eluting 66 ELIQUIS 66 LEUKINE 66 Nebido 66 Hematological Malignancies 66 Eraxis 66 Laquinimod 66 Frova ® 66 proteasome inhibitor 66 Submits NDA 66 Nivestim 66 LAF# 66 Phase #b/#a clinical 66 Maribavir 66 Pegintron 66 Vildagliptin 66 FUSILEV ® 66 Alogliptin 66 ZEVALIN ® 66 Panzem 66 Rebif ® 66 Tekamlo 66 anti inflammatory NSAID 66 Vicinium TM 66 Afinitor ® 66 EndoTAG TM -1 66 Onconase 66 Eltrombopag 66 delivers fluocinolone acetonide FA 66 topical NSAID 66 Adalimumab 66 RECOTHROM R 66 anticancer compound 66 tasocitinib 66 pain palliation 66 DORIBAX 66 ImClone Erbitux 66 Iloperidone 66 vidofludimus 66 rheumatoid arthritis psoriatic arthritis 66 Receives Marketing Authorization 66 Amgen Nplate 66 ARIXTRA R 66 Romidepsin 66 Ganciclovir 66 Phase III Trials 66 Teysuno 66 TREDAPTIVE 66 Inhalation Aerosol 66 histone deacetylase HDAC inhibitor 66 AZILECT R 66 LHRH antagonist 66 Taxotere ® 66 Sutent sunitinib 66 Gleevec imatinib mesylate 66 Annamycin 66 Talabostat 66 Enbrel etanercept 66 Zemplar Capsules 66 oral ridaforolimus 66 Arzerra 66 sunitinib Sutent 66 CCX# B 66 dual endothelin receptor antagonist 66 Gemzar ® 66 Xeloda ® 66 Lilly Gemzar 66 memantine HCl 66 HoFH 66 sunitinib malate 66 Epilepsy Drug 66 Bonefos 66 Zytiga 66 Promacta 66 PrevOnco 66 PEGylated anti 66 Perindopril 66 Randomized Phase II 66 Arzerra TM 66 Canvaxin 66 Initiate Phase 66 CIMZIA TM certolizumab pegol 66 Simulect 66 phase IIa clinical 66 Auxilium Pharma 66 herpetic keratitis 66 neovascular age 66 Troxatyl 66 Ciclesonide 66 Eribulin 66 Nexavar tablets 66 Dose Escalation 66 Increlex R 66 Relapsed Multiple Myeloma 66 Corlux 66 Aztreonam Lysine 66 Femara letrozole 66 Phase IIIb clinical 66 Drug Fails 66 BZL# 66 Tofacitinib 66 HCV Protease Inhibitor 66 FDA Approvable Letter 66 phase III isavuconazole 66 Lodotra TM 66 Phase 2b Trial 66 anidulafungin 66 Apixaban 66 Telmisartan 66 bazedoxifene 66 Zemplar 66 PKC# 66 Recombinant Human 66 VALSTAR 66 Sprycel dasatinib 66 HuMax TAC 66 metaglidasen 66 severe hypercholesterolemia 66 MKC# MT 66 Pradaxa ® 66 PROMACTA 66 mild vasodilator 66 CoFactor 66 cediranib 66 Demonstrates Significant 66 Kidney Transplant Patients 66 RhuDex TM 66 Xcytrin R 66 romiplostim 66 seliciclib CYC# 66 Arcalyst 66 oropharyngeal candidiasis 66 LymphoStat B TM 66 roflumilast 66 vemurafenib 66 Valtropin 66 brand ciclesonide HFA 66 Investigational Drug 66 ThGRF 66 Remicade infliximab 66 cathepsin K inhibitor 66 Zenvia Phase III 66 Telbivudine 66 Voreloxin 66 post menopausal osteoporosis 66 Plicera 66 injectable enzyme 66 Natalizumab 66 Onalta 66 OncoVEX GM CSF 66 orphan designation 66 Zebinix R 66 mapatumumab 66 Telzir 66 Besivance 66 Xelox 66 CINQUIL 66 brivaracetam 66 Wafer polifeprosan 66 Dyloject TM 66 Herceptin trastuzumab 66 ARCOXIA 66 PDUFA Date 66 Proquin XR 66 Dementia Related Psychosis 66 Daliresp 66 Motesanib 66 EOquin TM 66 Alfimeprase 66 baminercept 66 FASLODEX 66 DPP4 66 Rotigotine 66 IMiDs ® compound 66 SJIA 66 oral rivaroxaban 66 Drug Eluting Stent System 66 Initiate Phase III 66 Lilly Cymbalta 66 Ophena TM 66 Orphan Drug status 66 JOULFERON 66 Cellegesic 66 BAL# [002] 66 Luveniq 66 Hexvix 66 JAK2 Inhibitor 66 SIR Spheres 66 BCG refractory carcinoma 66 Phase 1b Clinical Trial 65 RNAi Therapeutic 65 Tacrolimus 65 MEK Inhibitor 65 Erbitux cetuximab 65 INCB# [003] 65 miconazole Lauriad ® 65 Emezine 65 Revolade 65 pulmonary arterial hypertension PAH 65 Tykerb lapatinib 65 PROVENGE ® 65 SEROQUEL R 65 Kit CD# positive 65 Epirubicin 65 investigational humanized monoclonal antibody 65 Ziprasidone 65 First Patient Dosed 65 Novel Antibiotic 65 investigational monoclonal antibody 65 FIRMAGON R 65 Azilect ® 65 Apaziquone 65 Novel Mechanism 65 PREOS 65 Bifeprunox 65 docetaxel Taxotere R 65 hormone agonist 65 DC Bead 65 novel nucleoside analog 65 HepaSphere 65 Initiate Phase II 65 intravitreal insert 65 beta 1a 65 Eli Lilly Cymbalta 65 IRX 2 65 desvenlafaxine 65 ATL# [001] 65 Tracleer ® 65 Lysteda 65 oral anticoagulant 65 AA amyloidosis 65 GTC recombinant form 65 Temodar ® 65 Zolinza 65 metastatic castration resistant 65 antibody MAb 65 XIAFLEX ® 65 TH# [003] 65 Cloretazine ® 65 Arranon 65 biliary tract cancer 65 Calcium Acetate 65 pirfenidone 65 Orathecin 65 tiapamil 65 Kynapid 65 Oral Calcitonin 65 paclitaxel poliglumex 65 PROVENGE sipuleucel T 65 Xanafide 65 REYATAZ R 65 OncoVex 65 Votrient 65 Orapred ODT 65 Alitretinoin 65 L BLP# 65 Azedra 65 Sorafenib 65 TYZEKA 65 Eluting Coronary Stent System 65 Cloretazine 65 Prostate Cancer Vaccine 65 Vidofludimus 65 Benlysta belimumab 65 Elotuzumab 65 Duloxetine 65 CIMZIA TM 65 Nimotuzumab 65 Omalizumab 65 label Lipofen R 65 Fludara ® 65 Kuvan R 65 STEDESA 65 BrachySil TM 65 Saforis 65 Alexion Pharma 65 Hepatocellular Carcinoma HCC 65 Quinamed 65 OMP designation 65 AFREZZA TM 65 Tipranavir 65 XGEVA 65 Vertex hepatitis C 65 SPL# Gel vaginal microbicide 65 Avanafil 65 GAMMAGARD 65 Sirolimus eluting Coronary Stent 65 ZEGERID Capsules 65 Dacogen decitabine 65 OvaRex ® MAb 65 Tiotropium 65 teriflunomide 65 balsalazide tablet 65 phase IIb trial 65 Arixtra 65 Hexvix ® 65 Fibrin Patch 65 SEROQUEL XR 65 angiotensin II receptor blocker 65 autologous cellular immunotherapy 65 TAXUS Element Stent System 65 Rivastigmine 65 Cholesterol Drug 65 pan HDAC inhibitor 65 intravenous AAT 65 Complicated Skin 65 Anturol TM 65 Emend 65 lurasidone 65 Phase IIIb 65 Soriatane 65 Fx #A 65 ankylosing spondylitis psoriatic arthritis 65 Increlex ® 65 Cimzia 65 Aplidin 65 Rheumatoid Arthritis RA 65 Taxotere docetaxel 65 pregabalin Lyrica 65 Bicifadine 65 Onyx Pharmaceuticals Announces 65 Aurexis 65 formerly LymphoStat B 65 pertuzumab 65 BENLYSTA TM 65 Dendreon Provenge 65 Nitazoxanide 65 ELND# 65 ocrelizumab 65 Aztreonam 65 Inhalation Solution 65 Osteoporosis Drug 65 Oral Formulation 65 Viviant 65 Vaprisol 65 Loramyc R 65 LUMINATE 65 BioDelivery Sciences Announces 65 Octreolin 65 Antitumor Activity 65 Rasagiline 65 Neupro 65 guanfacine extended release 65 Vidaza R 65 Sevelamer 65 Monotherapy 65 AstraZeneca Symbicort 65 Fibrillex TM 65 Olmesartan 65 JAK inhibitor 65 Levofloxacin 65 Mg Uk 65 Etravirine 65 OPAXIO TM 65 Tracleer r 65 huC# DM4 65 evaluating REVLIMID 65 Bremelanotide 65 Medidur ™ FA 65 Iressa gefitinib 65 Phase 2a Study 65 IMiDs R 65 Saphris 65 SEROQUEL 65 ANCHOR trial 65 Allovectin 7 65 dimebon latrepirdine 65 ZACTIMA TM ZD# 65 Intravitreal 65 Cutaneous T 65 relapsing multiple sclerosis 65 targeted radiotherapeutic 65 Nipent R 65 Survival Benefit 65 ORENCIA R 65 VitiGam 65 bevacizumab Avastin 65 Perifosine 65 Teriflunomide 65 interferon beta 1b 65 TYGACIL 65 R adalimumab 65 Cabazitaxel 65 MERREM 65 Bronchiectasis 65 Ramipril 65 Relovair 65 dasatinib Sprycel ® 65 Abiraterone 65 Announces Tentative Approval 65 Telaprevir 65 INTEGRILIN R 65 #D#C# 65 Zavesca 65 Zoloft sertraline 65 R bendamustine hydrochloride 65 ATPace TM 65 canakinumab 65 LIALDA 65 Zingo TM 65 esophageal candidiasis 65 T Pred 65 Phase IIb Clinical Trial 65 Aloxi R 65 PDX pralatrexate 65 CYP#A# substrate 65 Overactive Bladder 65 AAG geldanamycin analog 65 vinorelbine tartrate 65 Efficacy Results 65 forodesine 65 Factor Xa inhibitor 65 Intervention Effectiveness 65 Navelbine ® 65 Halaven 65 BioMatrix 65 UCB Cimzia 65 tramiprosate Alzhemed TM 65 Syndrome LEMS 65 TELINTRA 65 gefitinib Iressa 65 Bendamustine 65 CYT# QbG# 65 registrational trial 65 TREANDA 65 ularitide 65 efaproxiral 65 albinterferon alfa 2b 65 Eli Lilly Alimta 65 Alkeran 65 Pixantrone 65 Varespladib 65 Oral Spray 65 ThermoDox ® 65 Brentuximab Vedotin SGN 65 Fidaxomicin 65 Keppra ® XR 65 miconazole MBT 65 Cimzia certolizumab pegol 65 reduce serum phosphate 65 Actonel risedronate 65 nucleotide analogue 65 Pemphigus Vulgaris 65 Diamyd Medical Diamyd 65 StaphVAX R 65 castrate resistant prostate cancer 65 severe gastroparesis 65 TRANSDUR ® 65 Topotecan 65 Serdaxin 65 DEXILANT 65 APTIVUS 65 Novel Oral 65 Abbokinase 65 Orphan Designation 65 Files IND 65 torezolid phosphate 65 novel VDA molecule 65 Exelon rivastigmine 65 Kepivance 65 Removab 65 Tamibarotene 65 FTY# 65 sublingual tablets 65 Triolex 65 tafamidis 65 Levetiracetam 65 Microspheres 65 Tygacil 65 idiopathic pulmonary fibrosis IPF 65 Receives Approvable Letter 65 Phase 2b Study 65 orBec 65 Sanvar R 65 metastatic colorectal 65 olaparib 65 kidney urologic 65 Darinaparsin 65 XIAPEX ® 65 Afinitor everolimus 65 Budesonide 65 Infliximab 65 COMFORT II 65 Acute Ischemic Stroke 65 chronic idiopathic thrombocytopenic purpura 65 Entocort 65 IMiDs ® 65 IPLEX 65 antiplatelet agent 65 GSK# [002] 65 Onco TCS 65 Abiraterone acetate 64 INTEGRILIN R eptifibatide Injection 64 Regeneron Pharma 64 atypical antipsychotic medication 64 DNAwithPap TM Test 64 omacetaxine mepesuccinate 64 Adentri 64 eosinophilic asthma 64 Renal Cell Carcinoma RCC 64 vandetanib 64 Diamyd R 64 Cardio Vascu Grow 64 multiple myeloma MM 64 Hepatitis B Vaccine 64 HDAC Inhibitor 64 IV Busulfex 64 SCHWARZ PHARMA 64 OHR/AVR# 64 Forsteo 64 Pioglitazone 64 evaluating tivozanib 64 Maraviroc 64 Keryx Biopharma 64 Exelixis XL# 64 Milnacipran 64 Accelerated Approval 64 Phase Ib II 64 Benign Prostatic Hyperplasia 64 PRIALT 64 Montelukast 64 Genasense R 64 FDA Approvals 64 Perforomist ™ Inhalation Solution 64 Recombinant interferon alpha 64 Demonstrates Efficacy 64 Epidermal Growth Factor Receptor 64 DIRECT Trial 64 Medoxomil 64 Xolegel 64 ofatumumab HuMax CD# 64 zafirlukast 64 Fluconazole 64 Palonosetron 64 RNAi Therapeutics 64 volociximab 64 ONGLYZA TM 64 refractory gout 64 Zileuton 64 ADAGIO study 64 oral prodrug 64 LymphoStat B 64 Campath alemtuzumab 64 Treatment Resistant 64 II Clinical Trial 64 ASCO GI 64 ambrisentan 64 evaluating picoplatin 64 Previously Treated 64 IMiDs 64 NP2 Enkephalin 64 biologic antibody